Australia's Optiscan Imaging to seek U.S. FDA nod for screening device; shares rise

Optiscan Imaging

01/06/2021 04:54

** Microscopic imaging and related technology developer
Optiscan Imaging Ltd  OIL.AX  rises as much as 4.2% to A$0.375
    ** Co says in process of submitting application to U.S. Food
and Drug Administration (FDA) 510(k) for market clearance of its
'InVivage' device  urn:newsml:reuters.com:*:nASX6PJb4D
    ** Co says it completed multiple internal and external
validation requirements for the 510(k) Application at its
premises and contract testing facilities in the United States
    ** InVivage is a device used for oral cancer screening
and/or surgery targeting patients with  severe health
consequences of late stage diagnosis of oral cancer
    ** OIL had risen over three-fold this year, as of last close
       

 (Reporting by Aditya Munjuluru in Bengaluru)
 ((aditya.srivastsav@thomsonreuters.com))